Decision-Making Support for Older Adults with Metastatic Breast Cancer

This study is looking at a new patient-centered decision-making support tool for older adults (age 65 and above) with metastatic breast cancer (cancer that has spread to other parts of the body). The tool helps patients and their care partners make choices about treatment. Researchers want to see if the tool is acceptable, appropriate, and practical to use. The study plans to enroll 150 participants. To join, you must have metastatic breast cancer, be 65 or older, be currently receiving or considering systemic treatment, and be able to speak and read English. The study's status is currently unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention (the decision-making support tool). It aims to enroll 150 participants.
What's involved
Participants will use the decision-making support tool. Researchers will measure how acceptable, appropriate, and feasible the tool is at 3 and 6 months after starting.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07599618

Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners

Not Yet Recruiting
NAAges 65+InterventionalSupportive care
University of Rochester
~150 participants
Updated 2026-05-26 on ClinicalTrials.gov
What's tested:Decision-making support tool

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient and care partner Acceptability of Intervention (AIM)
Measured over Time Point 2: Occurs 3 months after Time Point 1 start (+/- 3 weeks) Time Point 3: Occurs 6 months after Time Point 1 start (+/- 3 weeks)
+2 more outcomes measured
Metastatic Breast Cancer
1 sites across 1 states
New York1
Dr. Allison Magnuson Principal Investigator
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

  • Patient and care partner Acceptability of Intervention (AIM)Time Point 2: Occurs 3 months after Time Point 1 start (+/- 3 weeks) Time Point 3: Occurs 6 months after Time Point 1 start (+/- 3 weeks)

    Measure different aspects of intervention implementation. The AIM, IAM, and FIM measures were jointly developed through a consensus process involving 63 experts (e.g., implementation scientists, health professionals), and psychometric properties for the three scales have been established. All three scales were developed to evaluate fit or match of a potential intervention (acceptability measure evaluates personal fit to the individual, appropriateness measure evaluates the societal or technical fit, and the feasibility measure evaluates practical fit. Each scale has 4-items with a 5-point Likert scale response (total score 4-20 for each measure), for a total of 12 items for all three scales. No specialized training is needed to administer or score the measure and it is written at a 5th grade reading level. Although cut-off scores for interpretation are not available, higher scores indicate greater degree of acceptability, appropriateness, and feasibility respectively.

  • Intervention Appropriateness Measure (IAM)Time Point 2: Occurs 3 months after Time Point 1 start (+/- 3 weeks) Time Point 3: Occurs 6 months after Time Point 1 start (+/- 3 weeks)

    Measure different aspects of intervention implementation. The AIM, IAM, and FIM measures were jointly developed through a consensus process involving 63 experts (e.g., implementation scientists, health professionals), and psychometric properties for the three scales have been established. All three scales were developed to evaluate fit or match of a potential intervention (acceptability measure evaluates personal fit to the individual, appropriateness measure evaluates the societal or technical fit, and the feasibility measure evaluates practical fit. Each scale has 4-items with a 5-point Likert scale response (total score 4-20 for each measure), for a total of 12 items for all three scales. No specialized training is needed to administer or score the measure and it is written at a 5th grade reading level. Although cut-off scores for interpretation are not available, higher scores indicate greater degree of acceptability, appropriateness, and feasibility respectively.

  • Feasibility of Intervention (FIM)Time Point 2: Occurs 3 months after Time Point 1 start (+/- 3 weeks) Time Point 3: Occurs 6 months after Time Point 1 start (+/- 3 weeks)

    Measure different aspects of intervention implementation. The AIM, IAM, and FIM measures were jointly developed through a consensus process involving 63 experts (e.g., implementation scientists, health professionals), and psychometric properties for the three scales have been established. All three scales were developed to evaluate fit or match of a potential intervention (acceptability measure evaluates personal fit to the individual, appropriateness measure evaluates the societal or technical fit, and the feasibility measure evaluates practical fit. Each scale has 4-items with a 5-point Likert scale response (total score 4-20 for each measure), for a total of 12 items for all three scales. No specialized training is needed to administer or score the measure and it is written at a 5th grade reading level. Although cut-off scores for interpretation are not available, higher scores indicate greater degree of acceptability, appropriateness, and feasibility respectively.